image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Reach - Data driven revenues up 56%

April 2023

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RCH
  • Price:
  • 75p
Although the shares fell on results, these were in line and crucially its digital growth strategy remains on track. Revenues and operating profit were down  2% and 27%, respectively, to £601m and £106m due to uglier advertising markets and rising costs. Operating expenses rose 5% to £477.9m with newsprint costs up 60%, but cost mitigation (reduced pagination and print runs) limited operating margin decline to 17% (down 0.6%). On the positive side, gas costs are now plummeting and supply chains normalising, which will reduce costs in 2023, as will a £30m cost reduction plan. Net cash fell to £25.4m after paying £55.8m into the pension, £17.1m deferred payment for Express & Star newspapers and £11m for phone hacking provisions, but liq ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author